Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-06-12 16:10:12 ET · period of report 2026-06-11 · accession 0002014639-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-12 16:10 | 2026-06-11 | INDV | Heidbreder Christian | CSO | S - Sale | $38.06 | -18.6K | 227.9K | -8% | -$707.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | S | D | 18,586 | $38.06 | 227,923 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. |